These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5920870)

  • 1. Effect of heparin on the fibrinolytic system.
    Silver D; Hall JH
    Surg Forum; 1966; 17():11-3. PubMed ID: 5920870
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin-adrenaline complex as a humoral agent of the anticoagulation system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1971; 17(1):46-53. PubMed ID: 5555145
    [No Abstract]   [Full Text] [Related]  

  • 4. [The protective effect of the arginine-heparin complex under simulation of insulin-dependent diabetes].
    Ul'ianov AM; Obergan TIu; Shubina TA; Pastorova VE; Liapina LA
    Izv Akad Nauk Ser Biol; 2010; (1):109-14. PubMed ID: 20235435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin-heparin complex, its physiological properties].
    Kudriashov BA; Pytel' IuA; Liapina LA; Baskakova GM
    Vopr Med Khim; 1981; 27(4):547-52. PubMed ID: 7027617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin-trypsin complex and its effect on blood fibrinolytic properties in vitro and in vivo].
    Kudriashov BA; Klishevskaia TM; Bazaz'ian GG; Poliakova LA
    Vopr Med Khim; 1965; 11(3):45-52. PubMed ID: 5867957
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of heparin and venous stasis on the fibrinolytic activity of the blood].
    Popławski A; Myśliwiec M; Soszka J; Rydzewski A; Rowiński M
    Pol Tyg Lek; 1986 Jun; 41(22):707-9. PubMed ID: 3748870
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin effect on platelets and fibrinolysis.
    Wahba A; Rothe G; Schmitz G; Birnbaum DE
    Ann Thorac Surg; 1996 May; 61(5):1590-1. PubMed ID: 8634001
    [No Abstract]   [Full Text] [Related]  

  • 11. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ellagic acid upon the rabbit fibrinolytic system.
    Iatridis SG; Iatridis PG
    Thromb Diath Haemorrh; 1972 Feb; 27(1):63-71. PubMed ID: 4113667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of antibiotics of glycopeptide structure on the content of fibrinogen and fibrinolytic activity of blood].
    Ivleva AIa
    Farmakol Toksikol; 1969; 32(6):719-23. PubMed ID: 5381605
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemistry and pharmacology of low molecular weight heparin.
    Rosenberg RD
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):2-8. PubMed ID: 9399404
    [No Abstract]   [Full Text] [Related]  

  • 15. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
    Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
    Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of the fibrinolytic system following subcutaneous administration and inhalation of heparin].
    Psuja P; Tokarz A; Turowiecka Z; Sowier J; Zawilska K
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):105-8. PubMed ID: 8361902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of supraceliac aortic clamping on the anticoagulant effects of heparin.
    Money SR; Ballinger BA; Crockett DE; Chatman DM; Lohmann TP
    Am J Surg; 1996 Aug; 172(2):155-7. PubMed ID: 8795520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of heparin on fibrinolysis, complement, and kinin generation systems (author's transl)].
    Nakagawa M; Kitani T
    Rinsho Ketsueki; 1981 Jul; 22(7):1016-22. PubMed ID: 7328761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.